Fundraising FoxCurie Capital
Venture capitalAmsterdam · Seed–Series A · 8 people tracked
Find your way into Curie Capital
1,963 people in our graph can introduce you to the Curie Capital team.
Sign up to see every warm intro you have to Curie Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curie Capital team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Curie Capital backs early-stage Life Sciences companies, investing at Seed and Series A stages in biotechnology, pharmaceutical, and medical technology firms typically focused on therapeutics, diagnostics, or class IIb and III medical devices. The firm typically leads rounds and syndicates alongside experienced co-investors, supporting portfolio companies with hands-on operational expertise and network access. Under its current fund (Curie Capital 3), it complies with RVO seed capital regulations and invests only in companies with a Dutch headquarters that have not raised more than €3.5 million in equity and/or convertible loans.
Source: firm website, verified Aug 3, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 7 of 7 portfolio companiesBiotech ×6Healthtech ×5Medical Devices ×5AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Hardware ×1Longevity ×1
HQs:Netherlands×5
Investments · 7 tracked
founders shown can be your intro pathAllero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease.
BiotechHealthtechMedical Devices
Emil Pot(CEO)Federico Grego(CFO)Poul Sørensen(CSO)in
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Robert Friesen(Founder)in
Co-investorsBioGeneration VenturesEQT Life SciencesBOMKurma PartnersV-Bio Ventures
Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.
BiotechHealthtechMedical DevicesOss, NL
Renato Chirivi(Co-founder (former CSO))in
BoardPaul Peter Tak(Chair of the Board)
Co-investorsBioGeneration VenturesPureos BioventuresSeventure PartnersForbionJohnson & Johnson Innovation – JJDCBOM+1 more
Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.
BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL
Peter de Keizer(Founder and Managing Director)inTobias Madl(Head of Structural Biology, Scientific Co-founder)
Co-investorsCoastCapFJ LabsKorify CapitalApollo Health VenturesKurma PartnersROM Utrecht Region
Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.
BiotechHealthtech
Co-investorsAngelini VenturesKurma Partners
TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.
BiotechMedical DevicesUtrecht, NL
Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in
Co-investorsAndera PartnersBioGeneration VenturesFund+Hadean VenturesInkefRotrip+1 more
Portfolio news
latest coverage across their companiesAvidicure · avidicure.com · Jun 27, 2025
Frequently asked questions
- How many investments has Curie Capital made?
- Curie Capital has 7 tracked investments.
- What stage does Curie Capital invest at?
- Curie Capital invests at the Seed, Series A stages.
- What sectors does Curie Capital focus on?
- Curie Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Curie Capital located?
- Curie Capital is headquartered in Amsterdam, NL.
- Does Curie Capital lead rounds?
- Yes, Curie Capital leads investment rounds.
- Who does Curie Capital co-invest with?
- Curie Capital most often shares deals with BioGeneration Ventures, BOM, Kurma Partners, among 16 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.